Pure Global AI
ANVISA registration 80254180473Valid until Feb 10, 2035

ANTI-TSH RECEPTOR ANTIBODY (TRAb) - NEONATAL SCREENING

ANVISA Registration Number: 80254180473PHADIA DIAGNOSTICOS LTDAB·R·A·H·M·S GMBHRisk Class III
Verified
Device names
Technical name
ANTI-TSH RECEPTOR ANTIBODY (TRAb) - NEONATAL SCREENING
View exact technical-name matches →
PT: ANTICORPO ANTI-RECEPTOR DE TSH (TRAb) - TRIAGEM NEONATAL
Commercial name
Família BRAHMS TRAK human KRYPTOR
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
80254180473
Process Number
25351412106202489
CNPJ
04930429000139
Company information
Registration Holder
PHADIA DIAGNOSTICOS LTDA
Manufacturer
B·R·A·H·M·S GMBH
Manufacturing Country
Germany
PT: ALEMANHA
Dates and status
Publication Date
Feb 10, 2025
Validity
10/02/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTI-TSH RECEPTOR ANTIBODY (TRAb) - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180473 and manufactured by B·R·A·H·M·S GMBH. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until Feb 10, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.